Wed, July 6, 2022

William Maughan Initiated (BCYC) at Strong Buy and Held Target at $60 on, Jul 6th, 2022

William Maughan of Canaccord Genuity, Initiated "Bicycle Therapeutics plc" (BCYC) at Strong Buy and Held Target at $60 on, Jul 6th, 2022.

William has made no other calls on BCYC in the last 4 months.



There are 4 other peers that have a rating on BCYC. Out of the 4 peers that are also analyzing BCYC, 1 agrees with William's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Kalpit Patel of "B. Riley Securities" Downgraded from Strong Buy to Hold and Decreased Target to $33 on, Wednesday, April 13th, 2022


These are the ratings of the 3 analyists that currently disagree with William


  • Edward Tenthoff of "Piper Sandler" Maintained at Buy with Decreased Target to $37 on, Monday, May 23rd, 2022
  • Jonathan Chang of "SVB Leerink" Maintained at Buy with Decreased Target to $69 on, Friday, May 6th, 2022
  • Ami Fadia of "Needham" Maintained at Strong Buy with Decreased Target to $75 on, Tuesday, April 12th, 2022